THE CONTRACTUAL STRUCTURE AND INNOVATIVE EFFECTS OF PHARMACEUTICAL-BIOTECHNOLOGY R&D COLLABORATIONS

Abstract

This study investigates the conditions that shape the contractual structure of pharmaceutical-biotechnology R&D agreements and whether these collaborations have produced measurable impact on the overall R&D productivity of pharmaceutical companies. In one section, the effect of uncertainty due to the advances in technology on the structure of R&D contracts is discussed. Specifically, it is shown that newer technologies associated with higher uncertainty result in the choice of more hierarchical contract structures. In addition, the significance of R&D collaborations on the overall innovation process of pharmaceutical companies is evaluated. The results indicate that only some types of R&D alliances, signed in earlier stages of research, have a significant role in the patent production and drug discovery process.

Citation

Kocabiyik Hansen, Z. (2003), "THE CONTRACTUAL STRUCTURE AND INNOVATIVE EFFECTS OF PHARMACEUTICAL-BIOTECHNOLOGY R&D COLLABORATIONS", Libecap, G.D. (Ed.) Issues in Entrepeneurship (Advances in the Study of Entrepreneurship, Innovation and Economic Growth, Vol. 14), Emerald Group Publishing Limited, Leeds, pp. 1-19. https://doi.org/10.1016/S1048-4736(02)14001-X